MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1080/17512433.2017.1371011

Медицинская библиотека · Expert review of clinical pharmacology · 2017

Calcifediol to treat secondary hyperparathyroidism in patients with chronic kidney disease.

Galassi Andrea, Bellasi Antonio, Ciceri Paola, Pivari Francesca, Conte Ferruccio, Cozzolino Mario

Сравнительное исследованиеСтатьяОбзорПеревод пока не подготовлен

Аннотация

Deranged vitamin D metabolism represents an active trigger of secondary hyperparathyroidism (SHPT) in CKD. Correction of 25(OH)D deficiency by nutritional Vitamin D administration is suggested by KDIGO guidelines, to prevent and treat SHPT in CKD stage G3-G5 and G1T-G5T patients, although with a still inconsistent background. Nutritional vitamin D is available as cholecalciferol, ergocalciferol, or calcifediol. Superiority of calcifediol in increasing 25(OH)D levels has been suggested due to its better bioavailability. The safer pharmacokinetic of the recent modified-release (MR) formulation of calcifediol was effective in replenishing 25(OH)D levels with minimal impact on vitamin D catabolism and fibroblast-growth factor-23 (FGF-23) activation. Areas covered: the review discusses utility of calcifediol for treating SHPT in different CKD stages under physiology driven approach, focusing on vitamin D metabolism, guidelines suggestions and comparison between clinical effects on SHPT elicited by calcifediol, cholecalciferol and ergocalciferol. Expert commentary: although optimal targets of 25(OH)D and parathormone remain uncertain, calcifediol, especially in its newer MR formulation, may represent an intriguing option to combine an efficacious correction of 25(OH)D deficit and SHPT, with a limited impact on vitamin D catabolism and FGF-23 activation. Newer data are required to better explore the role of MR calcifediol in treating SHPT.

Для цитирования: Galassi Andrea, Bellasi Antonio, Ciceri Paola, Pivari Francesca, Conte Ferruccio, Cozzolino Mario. Calcifediol to treat secondary hyperparathyroidism in patients with chronic kidney disease.. Expert review of clinical pharmacology. 2017. DOI: 10.1080/17512433.2017.1371011.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.